D1 and D2 dopamine and opiate receptors are involved in the restraint stress-induced sensitization to the psychostimulant effects of amphetamine

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 9-14

  Díaz Otañez, Claudia Soledad ^a   Capriles, Nancy Del Rosario ^a   Cancela, Liliana Marina ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Adaptation; Amphetamine; D1 and D2 dopamine receptors; Locomotor activity; Opoid system; Restraint; Sensitization; Stress

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL; NALTREXONE; OPIATE RECEPTOR; SULPIRIDE; CENTRAL STIMULANT AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; EXERCISE; MENTAL STRESS; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; TIME; WISTAR RAT;

AMPHETAMINE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; NALTREXONE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, OPIOID; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 0031226549     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00344-9     Document Type: Article

References (39)

1. Amir S., Brown Z. W., Amit Z. The role of endorphins in stress evidence and speculations. Neurosci. Biobehav. Res. 4:1980;77-86.
2. Antelman S. M., Eichler A. J., Black C. A., Kocan D. Interchangeability of stress and amphetamine in sensitization. Science. 207:1980;329-331.
3. Basso A. M., Depiante-Depaoli M., Cancela L., Molina V. A. Chronic restraint attenuates the immunosuppressive response induced by novel aversive stimuli. Physiol. Behav. 55:1994;1151-1155.
4. 2 dopamine receptors accompanies cocaine-induced behavioral sensitization. Brain Res. 639:1994;228-232.
5. Cabib S., Kempf E., Schleef C., Mele A., Puglisi-Allegra S Different effects of acute and chronic stress on two dopamine-mediated behaviors in the mouse. Physiol. Behav. 43:1988;223-277.
6. Cabib S., Puglisi-Allegra S., Oliveria A. Chronic stress enhances apomorphine-induced stereotyped behavior in mice. Involvement of endogenous opioids Brain Res. 298:1984;138-140.
7. Caggiula A. R., Antelman S. M., Aul E., Knopf S., Edwards D. J. Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine response to stress 10 days later. Psychopharmacology. 99:1989;233-237.
8. Cancela L. M., Bregonzio C., Molina V. A. Anxiolytic-like effect induced by chronic stress is reversed by naloxone pretreatment. Brain Res. Bull. 36:1995;209-213.
9. Cancela L. M., Molina V. A. Reduced apomorphine induced sedation following chronic stress. Eur. J. Pharmacol. 134:1987;117-119.
10. Cancela L. M., Rossi S., Molina V. A. Effect of different restraint schedules on the immobility in the forced swim test. modulation by an opiate mechanism Brain Res. Bull. 26:1991;671-675.
11. Cancela L. M., Volosin M., Molina V. A. Gangliosides attenuate stress-induced changes on body weight, motor activity and on the behavioral response to 5-methoxy-N, N-dimethyltryptamine. Brain Res. Bull. 40(2):1996;105-110.
12. 1a receptors induced by chronic restraint. Eur. J. Pharmacol. 176:1990;313-319.
13. Cancela L. M., Volosin M., Molina V. A. Chronic stress attenuation of α-adrenoceptor reactivity is reversed by naltrexone. Pharmacol. Biochem. Behav. 31:1988;33-35.
14. Deroche V., Piazza P. V., Casolini P., Maccari S., Le Moal M., Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone release. Brain Res. 598:1992;343-348.
15. Hahn B., Zacharko R. M., Anisman H. Alterations of amphetamine elicited perseveration and locomotor excitation following acute and repeated stressor application. Pharmacol. Biochem. Behav. 25:1986;29-33.
16. Herman J. P., Stinus L., Le Moal M. Repeated stress increases locomotor response to amphetamine. Psychopharmacology. 84:1984;431-435.
17. Imperato A., Angelucci L., Casolini P., Zocchi A., Puglisi-Allegra S. Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Res. 577:1992;194-199.
18. Kalivas P. W., Abhold R. Enkephalin release into the ventral tegmental area in response to stress. Modulation of mesocorticolimbic dopamine Brain Res. 414:1987;339-348.
19. Kalivas P. W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
20. Kalivas P. W., Taylor S., Miller S. Jr. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization. J. Pharmacol. Exp. Ther. 235:1985;537-543.
21. Kennett G. A., Dickinson S. L., Curzon G. Enhancement of some 5-HT-dependent behavioral responses following repeated immobilization in rats. Brain Res. 330:1985;253-263.
22. Kuribara H., Uchihashi Y. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assesed by ambulatory activity in mice. J. Pharm. Pharmacol. 45:1993;1042-1045.
23. Leyton M., Stewart J. Preexposure to foot-shock sensitizes the locomotor response to subsequent systemic morphine and intra-nucleus accumbens amphetamine. Pharmacol. Biochem. Behav. 37:1990;303-310.
24. MacLennan A. J., Maier S. F. Coping and stress-induced potentiation of stimulant stereotypy in the rat. Science. 219:1983;1091-1093.
25. Molina V. A., Heysen Ch., Spear L. P. Chronic variable stress or chronic morphine facilities immobility in a forced swim test. Reversal by naloxone Psychopharmacology. 114:1994;433-440.
26. Molina V. A., Volosin M., Cancela M. L., Keller E. A., Murúa V. S., Basso A. M. Effect of chronic variable stress on monoamine receptors. Influence of imipramine administration Pharmacol. Biochem. Behav. 38:1990;335-340.
27. Ohi K., Mikuni M., Takahashi K. Stress adaptation an hypersensitivity in 5-HT neuronal systems after repeated footshock. Pharmacol. Biochem. Behav. 34:1989;603-608.
28. Otero Losada M. E. Changes in central GABAergic function following acute and repeated stress. Br. J. Pharmacol. 93:1988;483-490.
29. Piazza P. V., Mittleman G., Deminière J. M., Le Moal M., Simon H. Relationship between schedule-induced polydipsia-and amphetamine intravenous self-administration. Individual differences and role of experience. Behav. Brain Res. 55:1993;185-193.
30. Piazza P. V., Deminière J. M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
31. Piazza P. V., Deminière J. M., Le Moal M., Simon H. Stress-and pharmacologically induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1990;22-26.
32. Piazza P. V., Deminière J. M., Maccari S., Mormede P., Le Moal M., Simon H. Individual reactivity to novelty predicts probability of amphetmine self-administration. Behav. Pharmacol. 1:1990;339-345.
33. Simon H. Stress and pharmacologically induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res. 514:1985;151-154.
34. Robinson T. E., Angus A. L., Becker J. B. Sensitization to stress. The enduring effects of prior stress on amphetamine-induced rotational behavior Life Sci. 37:1985;1039-1042.
35. Stone E. A. Central cyclic AMP linked noradrenergic receptors. New finding on properties as related to the action of stress Neurosci. Biobehav. Rev. 11:1987;391-398.
36. Stone E. A., Platt J. E. Brain adrenergic receptors and resistance to stress. Brain Res. 237:1982;405-414.
37. 2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology. 98:1989;89-92.
38. Vezina P., Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499:1989;108-120.
39. Wilcox R. A., Robinson T. E., Becker J. B. Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivo. Eur. J. Pharmacol. 124:1986;375-376.